COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
ReAlta Life Sciences Appoints Howard Berman, Ph.D., as CEO and Kia Motesharei, Ph.D., as President and COO
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $18.00 price target on the stock.
Coya Therapeutics (COYA) was downgraded by Wall Street Zen from "hold
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $14.00 price target on the stock.
Form EFFECT Coya Therapeutics, Inc.
Form 424B3 Coya Therapeutics, Inc.
Form S-3 Coya Therapeutics, Inc.
Form 10-K Coya Therapeutics, Inc. For: Dec 31
Form 8-K Coya Therapeutics, Inc. For: Mar 16
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.